DK0406743T3 - Gastroprotektive farmaceutiske præparater indeholdende N-benzyl-N-(1S,5S)-6,6-dimethylbicyclo(3.1.1)hept-2-yl-ethoxy-ethyl)-morpholiniumsalte - Google Patents
Gastroprotektive farmaceutiske præparater indeholdende N-benzyl-N-(1S,5S)-6,6-dimethylbicyclo(3.1.1)hept-2-yl-ethoxy-ethyl)-morpholiniumsalteInfo
- Publication number
- DK0406743T3 DK0406743T3 DK90112542.7T DK90112542T DK0406743T3 DK 0406743 T3 DK0406743 T3 DK 0406743T3 DK 90112542 T DK90112542 T DK 90112542T DK 0406743 T3 DK0406743 T3 DK 0406743T3
- Authority
- DK
- Denmark
- Prior art keywords
- dimethylbicyclo
- hept
- ethoxy
- benzyl
- ethyl
- Prior art date
Links
- 230000002178 gastroprotective effect Effects 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- VJFDMWSELFMHMO-KXNJDZORSA-N 4-benzyl-4-[2-[2-[(1s,5s)-6,6-dimethyl-4-bicyclo[3.1.1]heptanyl]ethoxy]ethyl]morpholin-4-ium Chemical group C1([C@@]2(C[C@](CC1)(C2(C)C)[H])[H])CCOCC[N+]1(CC=2C=CC=CC=2)CCOCC1 VJFDMWSELFMHMO-KXNJDZORSA-N 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 231100000487 gastrotoxic Toxicity 0.000 abstract 1
- 230000002162 gastrotoxic effect Effects 0.000 abstract 1
- 230000002008 hemorrhagic effect Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3922387A DE3922387A1 (de) | 1989-07-07 | 1989-07-07 | N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0406743T3 true DK0406743T3 (da) | 1995-02-13 |
Family
ID=6384504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90112542.7T DK0406743T3 (da) | 1989-07-07 | 1990-06-30 | Gastroprotektive farmaceutiske præparater indeholdende N-benzyl-N-(1S,5S)-6,6-dimethylbicyclo(3.1.1)hept-2-yl-ethoxy-ethyl)-morpholiniumsalte |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5232686A (da) |
| EP (1) | EP0406743B1 (da) |
| JP (1) | JP3090211B2 (da) |
| KR (1) | KR0156926B1 (da) |
| AT (1) | ATE114969T1 (da) |
| AU (1) | AU633331B2 (da) |
| CA (1) | CA2020171C (da) |
| DE (2) | DE3922387A1 (da) |
| DK (1) | DK0406743T3 (da) |
| HU (1) | HU208081B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2748206B1 (fr) * | 1996-05-06 | 1998-07-31 | Solvay Pharma | Utilisation de bromure de pinaverium dans la prevention des phenomenes proliferatifs des cellules du tractus hepatodigestif et des maladies qui en resultent |
| MXPA03007888A (es) * | 2001-03-08 | 2003-12-04 | Astrazeneca Ab | Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos. |
| KR200479194Y1 (ko) | 2014-12-03 | 2015-12-31 | 왕기현 | 원단 해포장치 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2097032B1 (da) * | 1970-07-29 | 1973-08-10 | Berri Balzac | |
| US3845048A (en) * | 1971-07-06 | 1974-10-29 | Berri Balzac | Terpene derivatives |
| GB1438092A (en) * | 1974-01-09 | 1976-06-03 | Science Union & Cie | Benzene-sulphonamides and processes for their preparation |
-
1989
- 1989-07-07 DE DE3922387A patent/DE3922387A1/de not_active Withdrawn
-
1990
- 1990-04-23 KR KR1019900005677A patent/KR0156926B1/ko not_active Expired - Lifetime
- 1990-06-29 CA CA002020171A patent/CA2020171C/en not_active Expired - Lifetime
- 1990-06-30 EP EP90112542A patent/EP0406743B1/de not_active Expired - Lifetime
- 1990-06-30 DK DK90112542.7T patent/DK0406743T3/da active
- 1990-06-30 AT AT90112542T patent/ATE114969T1/de not_active IP Right Cessation
- 1990-06-30 DE DE59007910T patent/DE59007910D1/de not_active Expired - Lifetime
- 1990-07-02 HU HU904054A patent/HU208081B/hu unknown
- 1990-07-04 JP JP02175480A patent/JP3090211B2/ja not_active Expired - Lifetime
- 1990-07-06 AU AU58716/90A patent/AU633331B2/en not_active Expired
- 1990-07-06 US US07/548,718 patent/US5232686A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU633331B2 (en) | 1993-01-28 |
| KR910002446A (ko) | 1991-02-25 |
| EP0406743B1 (de) | 1994-12-07 |
| CA2020171A1 (en) | 1991-01-08 |
| DE59007910D1 (de) | 1995-01-19 |
| US5232686A (en) | 1993-08-03 |
| AU5871690A (en) | 1991-01-10 |
| HU208081B (en) | 1993-08-30 |
| JP3090211B2 (ja) | 2000-09-18 |
| DE3922387A1 (de) | 1991-01-17 |
| ATE114969T1 (de) | 1994-12-15 |
| JPH0344325A (ja) | 1991-02-26 |
| EP0406743A2 (de) | 1991-01-09 |
| HU904054D0 (en) | 1990-12-28 |
| KR0156926B1 (ko) | 1998-11-16 |
| HUT54497A (en) | 1991-03-28 |
| EP0406743A3 (en) | 1992-01-02 |
| CA2020171C (en) | 2002-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE8459T1 (de) | Pharmazeutische zubereitung in form eines polyacrylatfilmes und deren herstellung. | |
| ATE163849T1 (de) | Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure | |
| NO870241L (no) | Hypoglykemiske tiazolidindioner. | |
| FI875681L (fi) | Menetelmä farmaseuttisesti aktiivisten 4-(2,6,6-trimetyyli-sykloheks-1-enyl)-but-3-en-1-ynyylisubstituoitujen yhdisteiden valmistamiseksi | |
| NO168353C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2'-aminofenyl)-benzamidderivater | |
| FI903153A0 (fi) | 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel. | |
| DK0598770T3 (da) | Pyrazinderivater samt fremstilling og anvendelse deraf | |
| PT72435B (pt) | Process for the preparation of 2-<2-(1,4-benzodioxanyl)>-2-imi-dazoline and salts thereof having pharmaceutical effect | |
| ES2026304A6 (es) | Procedimiento de fabricacion de una forma de dosificacion de nicardipina. | |
| FI831388A0 (fi) | 2-/2'-hydroxi-3'-(1,1-dimetylpropylamino)-propoxi/- -fenylpropionfenon, syreadditionssalter av denna foerfarande foer framstaellning av denna och farmaceutiska sammansaettningar | |
| DK0406743T3 (da) | Gastroprotektive farmaceutiske præparater indeholdende N-benzyl-N-(1S,5S)-6,6-dimethylbicyclo(3.1.1)hept-2-yl-ethoxy-ethyl)-morpholiniumsalte | |
| NO162557C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner. | |
| NO156900C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater. | |
| KR890003374A (ko) | 정신 분열증 치료용 약제의 제조에 2-아미노-6-(트리플루오로메톡시)벤조티아졸의 이용 | |
| ATE5073T1 (de) | 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| PT85454A (de) | Verwendung von 15-deoxyspergualin als arzneimittel | |
| DE2960627D1 (en) | 2-(n-(2'chloro-4'-methyl-thienyl-3')-n-(cyclopropylmethyl)-amino) imidazoline (2), its acid addition salts, pharmaceutical preparations containing them and process for their preparation | |
| DK222588A (da) | 5-quinoxalyl-imidazolidin-2,4-dioner, deres fremstilling og anvendelse som laegemidler | |
| ZA875954B (en) | Oxirane pseudooligasaccharides,a process for their preparation,their use and pharmaceutical preparations | |
| FR2449450A1 (fr) | Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension | |
| IT7945204A0 (it) | Composizione farmaceutica per la terapia delle sterilita' maschile | |
| IT8448370A0 (it) | Citrato trisodico utilizzabile nella cura delle malattie artriticoreumatiche | |
| SE8900685D0 (sv) | New compounds | |
| KR880002520A (ko) | 망막증의 치료방법 | |
| IE780207L (en) | 4-hydroxy-1,2-benzisothiazole |